BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 24108355)

  • 1. Ligand-specific conformational change of the G-protein-coupled receptor ALX/FPR2 determines proresolving functional responses.
    Cooray SN; Gobbetti T; Montero-Melendez T; McArthur S; Thompson D; Clark AJ; Flower RJ; Perretti M
    Proc Natl Acad Sci U S A; 2013 Nov; 110(45):18232-7. PubMed ID: 24108355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annexin A1 interaction with the FPR2/ALX receptor: identification of distinct domains and downstream associated signaling.
    Bena S; Brancaleone V; Wang JM; Perretti M; Flower RJ
    J Biol Chem; 2012 Jul; 287(29):24690-7. PubMed ID: 22610094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for an anti-inflammatory loop centered on polymorphonuclear leukocyte formyl peptide receptor 2/lipoxin A4 receptor and operative in the inflamed microvasculature.
    Brancaleone V; Dalli J; Bena S; Flower RJ; Cirino G; Perretti M
    J Immunol; 2011 Apr; 186(8):4905-14. PubMed ID: 21398608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2/lipoxin A4 receptor.
    Dalli J; Consalvo AP; Ray V; Di Filippo C; D'Amico M; Mehta N; Perretti M
    J Immunol; 2013 Jun; 190(12):6478-87. PubMed ID: 23686496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Annexin A1 protects against cerebral ischemia-reperfusion injury by modulating microglia/macrophage polarization via FPR2/ALX-dependent AMPK-mTOR pathway.
    Xu X; Gao W; Li L; Hao J; Yang B; Wang T; Li L; Bai X; Li F; Ren H; Zhang M; Zhang L; Wang J; Wang D; Zhang J; Jiao L
    J Neuroinflammation; 2021 May; 18(1):119. PubMed ID: 34022892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation and cancer: role of annexin A1 and FPR2/ALX in proliferation and metastasis in human laryngeal squamous cell carcinoma.
    Gastardelo TS; Cunha BR; Raposo LS; Maniglia JV; Cury PM; Lisoni FC; Tajara EH; Oliani SM
    PLoS One; 2014; 9(12):e111317. PubMed ID: 25490767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electroacupuncture decreases inflammatory pain through a pro-resolving mechanism involving the peripheral annexin A1-formyl peptide receptor 2/ALX-opioid receptor pathway.
    Vieira C; Salm DC; Horewicz VV; Ludtke DD; Emer AA; Koerich JF; Mazzardo G; Elias S; Moré AOO; Mazzardo-Martins L; Cidral-Filho FJ; Reed WR; Piovezan AP; Martins DF
    Pflugers Arch; 2021 Apr; 473(4):683-695. PubMed ID: 33474635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocyte recruitment in the brain in sepsis: involvement of the annexin 1-FPR2/ALX anti-inflammatory system.
    Gavins FN; Hughes EL; Buss NA; Holloway PM; Getting SJ; Buckingham JC
    FASEB J; 2012 Dec; 26(12):4977-89. PubMed ID: 22964301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the AnxA1/Fpr2/ALX pathway regulates neutrophil function, promoting thromboinflammation resolution in sickle cell disease.
    Ansari J; Senchenkova EY; Vital SA; Al-Yafeai Z; Kaur G; Sparkenbaugh EM; Orr AW; Pawlinski R; Hebbel RP; Granger DN; Kubes P; Gavins FNE
    Blood; 2021 Mar; 137(11):1538-1549. PubMed ID: 33512489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the Annexin A1-FPR2/ALX pathway for host-directed therapy in dengue disease.
    Costa VV; Sugimoto MA; Hubner J; Bonilha CS; Queiroz-Junior CM; Gonçalves-Pereira MH; Chen J; Gobbetti T; Libanio Rodrigues GO; Bambirra JL; Passos IB; Machado Lopes CE; Moreira TP; Bonjour K; Melo RCN; Oliveira MAP; Andrade MVM; Sousa LP; Souza DG; Santiago HDC; Perretti M; Teixeira MM
    Elife; 2022 Mar; 11():. PubMed ID: 35293862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis.
    Maderna P; Cottell DC; Toivonen T; Dufton N; Dalli J; Perretti M; Godson C
    FASEB J; 2010 Nov; 24(11):4240-9. PubMed ID: 20570963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definition of a Novel Pathway Centered on Lysophosphatidic Acid To Recruit Monocytes during the Resolution Phase of Tissue Inflammation.
    McArthur S; Gobbetti T; Kusters DH; Reutelingsperger CP; Flower RJ; Perretti M
    J Immunol; 2015 Aug; 195(3):1139-51. PubMed ID: 26101324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formyl peptide receptors and the regulation of ACTH secretion: targets for annexin A1, lipoxins, and bacterial peptides.
    John CD; Sahni V; Mehet D; Morris JF; Christian HC; Perretti M; Flower RJ; Solito E; Buckingham JC
    FASEB J; 2007 Apr; 21(4):1037-46. PubMed ID: 17218541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-formyl peptide receptor 3 (FPR3) departs from the homologous FPR2/ALX receptor with regard to the major processes governing chemoattractant receptor regulation, expression at the cell surface, and phosphorylation.
    Rabiet MJ; Macari L; Dahlgren C; Boulay F
    J Biol Chem; 2011 Jul; 286(30):26718-31. PubMed ID: 21543323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mast cells mediate early neutrophil recruitment and exhibit anti-inflammatory properties via the formyl peptide receptor 2/lipoxin A
    Hughes EL; Becker F; Flower RJ; Buckingham JC; Gavins FNE
    Br J Pharmacol; 2017 Jul; 174(14):2393-2408. PubMed ID: 28471519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biased allosteric modulation of formyl peptide receptor 2 leads to distinct receptor conformational states for pro- and anti-inflammatory signaling.
    Zhang S; Gong H; Ge Y; Ye RD
    Pharmacol Res; 2020 Nov; 161():105117. PubMed ID: 32768626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Annexin A1, FPR2/ALX, and inflammatory cytokine expression in peritoneal endometriosis.
    Volpato LK; Horewicz VV; Bobinski F; Martins DF; Piovezan AP
    J Reprod Immunol; 2018 Sep; 129():30-35. PubMed ID: 30096622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement.
    Hayhoe RP; Kamal AM; Solito E; Flower RJ; Cooper D; Perretti M
    Blood; 2006 Mar; 107(5):2123-30. PubMed ID: 16278303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of Annexin A1 in Mice Upregulates the Expression of Its Receptor, Fpr2/3, and Reactivity to the AnxA1 Mimetic Peptide in Platelets.
    Zharkova O; Salamah MF; Babak MV; Rajan E; Lim LHK; Andrade F; Gil CD; Oliani SM; Moraes LA; Vaiyapuri S
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the annexin 1-formyl peptide receptor 2/ALX pathway affords protection against bacterial LPS-induced pathologic changes in the murine adrenal cortex.
    Buss NA; Gavins FN; Cover PO; Terron A; Buckingham JC
    FASEB J; 2015 Jul; 29(7):2930-42. PubMed ID: 25818588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.